Skip to main content
. Author manuscript; available in PMC: 2010 Nov 16.
Published in final edited form as: Tuberculosis (Edinb). 2009 Aug 20;89(5):364–370. doi: 10.1016/j.tube.2009.07.002

Figure 1.

Figure 1

Distribution of anti-tuberculosis activity in the Johns Hopkins Library of known drugs: 53 compounds exhibited more than 80% growth inhibition at 5 μM. Of these, 17 compounds were novel anti-tuberculosis agents: 3 of these were oral, 6 were intravenous and 8 were topical therapeutics.